{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:42:38Z","timestamp":1792464158071,"version":"4.5.0"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T00:00:00Z","timestamp":1314230400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1002195","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T20:56:21Z","timestamp":1314305781000},"page":"e1002195","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":119,"title":["Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin"],"prefix":"10.1371","volume":"7","author":[{"given":"Mostafa","family":"Jarahian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Cohnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Djandji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter J.","family":"H\u00e4mmerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Gati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelheid","family":"Cerwenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Moyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Watzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Momburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,8,25]]},"reference":[{"key":"ref1","first-page":"2905","article-title":"Poxviridae: The viruses and their replication.","volume":"2","author":"B Moss","year":"2007","journal-title":"Fields Virology"},{"key":"ref2","article-title":"Smallpox and its Eradication.","author":"F Fenner","year":"1988"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1073\/pnas.93.21.11341","article-title":"Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.","volume":"93","author":"B Moss","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-065X.1997.tb01012.x","article-title":"Vaccinia virus immune evasion.","volume":"159","author":"GL Smith","year":"1997","journal-title":"Immunol Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1146\/annurev.immunol.21.120601.141049","article-title":"Poxviruses and immune evasion.","volume":"21","author":"BT Seet","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/icb.1990.44","article-title":"Vaccinia virus-mediated damage of murine ovaries and protection by virus-expressed interleukin-2.","volume":"68","author":"G Karupiah","year":"1990","journal-title":"Immunol Cell Biology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"8301","DOI":"10.1128\/JVI.70.12.8301-8309.1996","article-title":"Different roles for CD4<sup>+<\/sup> and CD8<sup>+<\/sup> T lymphocytes and macrophage subsets in the control of a generalized virus infection.","volume":"70","author":"G Karupiah","year":"1996","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.4049\/jimmunol.166.11.6784","article-title":"Innate immunity to viruses: control of vaccinia virus infection by T cells.","volume":"166","author":"LK Selin","year":"2001","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.","volume":"100","author":"IM Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","article-title":"Cellular and humoral immunity against vaccinia virus infection of mice.","volume":"172","author":"R Xu","year":"2004","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.4049\/jimmunol.131.3.1531","article-title":"Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.","volume":"131","author":"JF Bukowski","year":"1983","journal-title":"J Immunol"},{"key":"ref12","first-page":"203","article-title":"Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression.","volume":"11","author":"RR Brutkiewicz","year":"1992","journal-title":"Nat Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01313742","article-title":"Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus.","volume":"108","author":"RO Jacoby","year":"1989","journal-title":"Arch Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1128\/JVI.02061-06","article-title":"Induction of natural killer cell responses by ectromelia virus controls infection.","volume":"81","author":"AK Parker","year":"2007","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1126\/science.8456301","article-title":"Immune response in mice that lack the interferon-gamma receptor.","volume":"259","author":"S Huang","year":"1993","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1128\/JVI.74.7.3404-3409.2000","article-title":"Impaired antiviral response and alpha\/beta interferon induction in mice lacking beta interferon.","volume":"74","author":"R Deonarain","year":"2000","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.4049\/jimmunol.180.3.1592","article-title":"Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo.","volume":"180","author":"J Martinez","year":"2008","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1128\/JVI.80.5.2225-2233.2006","article-title":"Recognition of vaccinia virus-infected cells by human natural killer cells depends on natural cytotoxicity receptors.","volume":"80","author":"SE Chisholm","year":"2006","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1371\/journal.ppat.0040030","article-title":"A role for NKG2D in NK cell-mediated resistance to poxviral disease.","volume":"4","author":"M Fang","year":"2008","journal-title":"PLoS Pathog"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.","volume":"19","author":"A Moretta","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition.","volume":"23","author":"LL Lanier","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.coi.2004.07.010","article-title":"Killer immunoglobulin-like receptors.","volume":"16","author":"L Moretta","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.semcancer.2006.07.005","article-title":"Tumor and viral recognition by natural killer cells receptors.","volume":"16","author":"TI Arnon","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.4049\/jimmunol.173.4.2392","article-title":"Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46.","volume":"173","author":"N Bloushtain","year":"2004","journal-title":"J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1021\/bi7000455","article-title":"Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44.","volume":"46","author":"O Hershkovitz","year":"2007","journal-title":"Biochemistry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/glycob\/cwm125","article-title":"Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immuno-receptors as an immunological tool.","volume":"18","author":"O Hershkovitz","year":"2008","journal-title":"Glycobiology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.immuni.2007.10.010","article-title":"Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.","volume":"27","author":"E Pogge von Strandmann","year":"2007","journal-title":"Immunity"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.20090681","article-title":"The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.","volume":"206","author":"CS Brandt","year":"2009","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e1339","DOI":"10.1371\/journal.pone.0001339","article-title":"Expression analysis of the ligands for the natural killer cell receptors NKp30 and NKp44.","volume":"2","author":"A Byrd","year":"2007","journal-title":"PLoS ONE"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/35059110","article-title":"Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells.","volume":"409","author":"O Mandelboim","year":"2001","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A","article-title":"Recognition of viral hemagglutinins by NKp44 but not by NKp30.","volume":"31","author":"TI Arnon","year":"2001","journal-title":"Eur J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ni1322","article-title":"Lethal influenza infection in the absence of the natural killer cell receptor gene <italic>Ncr1<\/italic>.","volume":"7","author":"R Gazit","year":"2006","journal-title":"Nat Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1128\/JVI.00211-09","article-title":"Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.","volume":"83","author":"M Jarahian","year":"2009","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ni1190","article-title":"Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.","volume":"6","author":"TI Arnon","year":"2005","journal-title":"Nat Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1086\/512862","article-title":"Expression of ICP0 is sufficient to trigger natural killer cell recognition of herpes simplex virus-infected cells by natural cytotoxicity receptors.","volume":"195","author":"SE Chisholm","year":"2007","journal-title":"J Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1073\/pnas.0504315102","article-title":"NK cytotoxicity against CD4<sup>+<\/sup> T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand.","volume":"102","author":"V Vieillard","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"10038","DOI":"10.1158\/0008-5472.CAN-07-0146","article-title":"Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.","volume":"67","author":"Q Zhang","year":"2007","journal-title":"Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1158\/1535-7163.MCT-08-0533","article-title":"Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.","volume":"8","author":"YA Yu","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1099\/vir.0.19285-0","article-title":"A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection.","volume":"84","author":"PC Reading","year":"2003","journal-title":"J Gen Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/1471-2164-10-301","article-title":"Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.","volume":"10","author":"A Worschech","year":"2009","journal-title":"BMC Genomics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s00262-009-0686-7","article-title":"The immunologic aspects of poxvirus oncolytic therapy.","volume":"58","author":"A Worschech","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.virol.2005.11.012","article-title":"The cowpox virus fusion regulator proteins SPI-3 and hemagglutinin interact in infected and uninfected cells.","volume":"347","author":"PC Turner","year":"2006","journal-title":"Virology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1128\/JVI.65.7.3598-3606.1991","article-title":"Molecular characterization of the vaccinia virus hemagglutinin gene.","volume":"65","author":"CK Brown","year":"1991","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood-2003-05-1716","article-title":"The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46.","volume":"103","author":"TI Arnon","year":"2004","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.188.5.953","article-title":"Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity.","volume":"188","author":"A Pessino","year":"1998","journal-title":"J Exp Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.190.10.1505","article-title":"Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells.","volume":"190","author":"D Pende","year":"1999","journal-title":"J Exp Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1182\/blood-2006-07-036509","article-title":"Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication.","volume":"109","author":"EN Nolte-'t Hoen","year":"2007","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/eji.200323896","article-title":"Selective cross-talk among natural cytotoxicity receptors in human natural killer cells.","volume":"33","author":"R Augugliaro","year":"2003","journal-title":"Eur J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.4049\/jimmunol.136.12.4674","article-title":"Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.","volume":"36","author":"L Stitz","year":"1986","journal-title":"J Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.immunol.17.1.189","article-title":"Natural killer cells in antiviral defense: function and regulation by innate cytokines.","volume":"17","author":"CA Biron","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.bmt.1701825","article-title":"Natural killer (NK) cells prevent virus production in cell culture.","volume":"2","author":"L Baraz","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1073\/pnas.93.21.11349","article-title":"Applications of pox virus vectors to vaccination: an update.","volume":"93","author":"E Paoletti","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO;2-O","article-title":"The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity.","volume":"29","author":"R Biassoni","year":"1999","journal-title":"Eur J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/molbev\/msi162","article-title":"NKp30 (NCR3) is a pseudogene in 12 inbred and wild mouse strains, but an expressed gene in Mus caroli.","volume":"22","author":"M Hollyoake","year":"2005","journal-title":"Mol Biol Evol"},{"key":"ref55","first-page":"2571","article-title":"Vaccinia virus hemagglutinin. A novel member of the immunoglobulin superfamily.","volume":"170","author":"DY Jin","year":"1989","journal-title":"J Exp Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/JVI.31.1.147-155.1979","article-title":"Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus.","volume":"31","author":"LG Payne","year":"1979","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1099\/0022-1317-83-10-2347","article-title":"An investigation of the incorporation of cellular antigens in vaccinia virus particles.","volume":"83","author":"O Krauss","year":"2002","journal-title":"J Gen Virol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virol.2008.07.020","article-title":"The vaccinia virus fusion inhibitor proteins SPI-3 (K2) and HA (A56) expressed by infected cells reduce the entry of superinfecting virus.","volume":"380","author":"PC Turner","year":"2008","journal-title":"Virology"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/JVI.01684-08","article-title":"Expression of the A56 and K2 proteins is sufficient to inhibit vaccinia virus entry and cell fusion.","volume":"83","author":"TR Wagenaar","year":"2009","journal-title":"J Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1128\/JVI.62.12.4474-4480.1988","article-title":"Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.","volume":"62","author":"H Shida","year":"1988","journal-title":"J Virol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00438-009-0475-1","article-title":"The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation.","volume":"282","author":"Q Zhang","year":"2009","journal-title":"Mol Genet Genomics"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1099\/0022-1317-79-4-877","article-title":"Intracellular and extracellular vaccinia virions enter cells by different mechanisms.","volume":"79","author":"A Vanderplasschen","year":"1998","journal-title":"J Gen Virol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.4049\/jimmunol.176.5.2915","article-title":"Expression of glycosylphosphatidylinositol-anchored CD59 on target cells enhances human NK cell-mediated cytotoxicity.","volume":"176","author":"N Omidvar","year":"2006","journal-title":"J Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1099\/0022-1317-76-12-2987","article-title":"Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells.","volume":"76","author":"H Hengel","year":"1995","journal-title":"J Gen Virol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"22370","DOI":"10.1074\/jbc.M704250200","article-title":"Identification of CLEC12B, an inhibitory receptor on myeloid cells.","volume":"2007. 282","author":"SC Hoffmann","year":"2007","journal-title":"J Biol Chem"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.cmr.0000222597.50309.05","article-title":"Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes.","volume":"16","author":"S Bloethner","year":"2006","journal-title":"Melanoma Res"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.gt.3302607","article-title":"Characterization of HLA-A2-restricted HPV-16 E7-specific CD8<sup>+<\/sup> T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.","volume":"13","author":"S Peng","year":"2006","journal-title":"Gene Ther"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/10430349950018030","article-title":"Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy.","volume":"10","author":"YK Tam","year":"1999","journal-title":"Hum Gene Ther"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/ijc.22579","article-title":"Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells.","volume":"120","author":"M Jarahian","year":"2007","journal-title":"Int J Cancer"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0042-6822(02)00017-X","article-title":"Plasma membrane localization and fusion inhibitory activity of the cowpox virus serpin SPI-3 require a functional signal sequence and the virus encoded hemagglutinin.","volume":"306","author":"LM Brum","year":"2003","journal-title":"Virology"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1002195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:38:06Z","timestamp":1686271086000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1002195"}},"subtitle":[],"editor":[{"given":"Wayne M.","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,25]]},"references-count":70,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1002195","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,25]]}}}